Therapeutic peptides for cancer therapy. Part II – cell cycle inhibitory peptides and apoptosis-inducing peptides

By Raucher Drazen   Moktan Shama   Massodi Iqbal   Bidwell III Gene L  

Expert Opinion on Drug Delivery, Vol. 6, Iss. 10, 2009-10 ,pp. : 1049-1064

Informa Healthcare

Access to resources Recommend Favorite

Cancer prevention by food factors through targeting signal transduction pathways

By Bode A.M.   Dong Z.  

Nutrition, Vol. 20, Iss. 1, 2004-01 ,pp. : 89-94

Elsevier

Access to resources Recommend Favorite

In vivo CTL induction with point-substituted ovalbumin peptides: immunogenicity correlates with peptide-induced MHC class I stability

By Lipford G.B.   Bauer S.   Wagner H.   Heeg K.  

Vaccine, Vol. 13, Iss. 3, 1995-01 ,pp. : 313-320

Elsevier

Access to resources Recommend Favorite

The CNS as a target for peptides and peptide-based drugs

By Banks William A  

Expert Opinion on Drug Delivery, Vol. 3, Iss. 6, 2006-11 ,pp. : 707-712

Informa Healthcare

Access to resources Recommend Favorite

Quality of life for head and neck cancer patients treated by combined modality therapy: the therapeutic benefit of technological advances in radiotherapy

By Huang Tai-Lin   Tsai Wen-Ling   Chien Chih-Yen   Lee Tsair-Fwu   Fang Fu-Min  

Quality of Life Research, Vol. 19, Iss. 9, 2010-11 ,pp. : 1243-1254

Springer Publishing Company

Access to resources Recommend Favorite